Type 1 diabetes, ageing and frailty: an underexplored intersection
Rattachement africain : gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Over recent decades, the life expectancy of individuals with type 1 diabetes has steadily improved due to advances in therapies that enhance metabolic control alongside better prevention and management of complications. However, this extended survival brings new challenges. Type 1 diabetes, through sustained hyperglycaemia and recurrent hypoglycaemia, may act as an accelerator of ageing, predisposing individuals to the development of geriatric syndromes such as frailty. Frailty, defined as a state of reduced physiological reserve that heightens susceptibility to stressors and impairs the ability to restore homeostasis after acute events, has emerged as a recognised complication of diabetes and has been associated with several adverse outcomes including increased risks of hypoglycaemia, hospitalisation, disability, institutionalisation and death. The putative pathophysiology of frailty in type 1 diabetes is complex and multifactorial. It reflects the direct effects of chronic exposure to hyperglycaemia and consequent micro- and macrovascular complications, superimposed on age- and diabetes-related hormonal changes. Additional contributors include sarcopenia, cognitive decline and other comorbidities. Currently, most of the literature on diabetes and frailty focuses on type 2 diabetes, while the relationship with type 1 diabetes and the impact on outcomes remain to be fully elucidated. In this review we discuss the growing evidence on the link between frailty and type 1 diabetes, explore its underlying pathophysiological mechanisms, discuss assessment and treatment strategies, and highlight the key knowledge gaps and suggest future research directions in this evolving field.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Type 1 diabetes, ageing and frailty: an underexplored intersection
- Date Crossref
- 17/02/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Epsom and St Helier University Hospitals NHS Trust Department of Diabetes and Endocrinology pays non établi dans la noticeÉtablissement de santé
-
King's College School pays non établi dans la noticeUniversité ou école supérieure
-
King's College London pays non établi dans la noticeUniversité ou école supérieure
-
Guy's and St Thomas' NHS Foundation Trust Department of Ageing and Health pays non établi dans la noticeÉtablissement de santé
-
University Hospitals Birmingham NHS Foundation Trust Department of Diabetes and Endocrinology pays non établi dans la noticeÉtablissement de santé
-
Aston University pays non établi dans la noticeUniversité ou école supérieure
-
School of Cardiovascular Medicine & Metabolic Sciences pays non établi dans la noticeUniversité ou école supérieure
-
School of Life Course and Population Sciences pays non établi dans la noticeUniversité ou école supérieure
-
College of Health and Life Sciences pays non établi dans la noticeUniversité ou école supérieure
Department of Diabetes and Endocrinology — Epsom and St Helier University Hospitals NHS Trust, King's College School et King's College London, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.